⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
Latest News
Pomerantz LLP Advises Investors of Class Action Filing Against Bank of America Corporation – BAC
accessnewswire.com
BAC
Pomerantz LLP Announces Securities Class Action Lawsuit Against D-Wave Quantum Inc. – QBTS
accessnewswire.com
QBTS
Pomerantz LLP Issues Reminder to Investors in Endava Plc of Class Action Lawsuit – DAVA
accessnewswire.com
DAVA
Pomerantz LLP Shares Class Action Details With Shareholders in Lincoln Educational Services Corp. – LINC
accessnewswire.com
LINC
AppLovin Corporation (APP) Class Action Lawsuit: Investors Face November 16, 2026, Deadline - Kessler Topaz Meltzer & Check, LLP
globenewswire.com
APP
SSTI Stock Alert: Halper Sadeh LLC is Investigating Whether SoundThinking, Inc. is Obtaining a Fair Price for its Shareholders
businesswire.com
SSTI
IMFINZI ® (durvalumab) plus tarlatamab-dlle reduced the risk of death by 58% in 1st-line extensive-stage small cell lung cancer in the DeLLphi-305 Phase III trial
businesswire.com
AZN
From Private Credit to Fusion Power: New to The Street Show #777 Premieres Tonight on Bloomberg Television
accessnewswire.com
BIVI
CAST
SWRD
ACXP
BSIN
TMC
RDZN
IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER
prnewswire.com
AMGN
Perioperative IMFINZI® (durvalumab) plus neoadjuvant enfortumab vedotin reduced risk of recurrence by 49% and risk of death by 42% in muscle-invasive bladder cancer
businesswire.com
AZN